Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds. On February 24, Iovance Biotherapeutics announced positive early data from a pilot ...
Among the key speakers was Associate Professor Johnny Ong, Head and Senior Consultant of the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT) at the National Cancer Cen ...
The Punch on MSN
Scientist urges investment in bone cancer research
A United States-based Nigerian cancer scientist, Rahmon Kanmodi, has called for increased investment in musculoskeletal cancer research across Africa, with particular focus on Nigeria.Kanmodi, a ...
BioAtla has engaged Tungsten Advisors as the Company’s exclusive strategic financial advisor. There can be no assurance that this process will result in any such transaction. BioAtla does not intend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results